Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Kallyope

News headline image
Kallyope Presents New Data on Novel TRPM8 Channel Blocker Elismetrep for the Acute Treatment for Migraine at the American Headache Society 68th Annual Scientific Meeting
From Kallyope
Via Business Wire
News headline image
Kallyope’s Phase 2b Study of Elismetrep, A Novel Approach for Treating Migraine, Presented at the American Academy of Neurology Annual Meeting
From Kallyope
Via Business Wire
News headline image
Kallyope to Present Phase 2b Study Results for Elismetrep for the Acute Treatment of Migraine at the 2026 American Academy of Neurology Annual Meeting
From Kallyope
Via Business Wire
News headline image
Kallyope Announces 2026 Strategic Priorities for Migraine and Metabolism Portfolio Based on Novel Neural Circuits Platform
From Kallyope
Via Business Wire
News headline image
Kallyope To Present at the 44th Annual J.P. Morgan Healthcare Conference
From Kallyope
Via Business Wire
News headline image
Kallyope Announces Positive Results from Phase 2b Study of Elismetrep for the Acute Treatment of Migraine
From Kallyope
Via Business Wire
News headline image
Kallyope Announces License Agreement with Novo Nordisk
From Kallyope
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.